News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zhejiang Hisoar Pharmaceutical (SHE) Given Japanese Approval for Antibiotic



3/19/2012 1:47:56 PM

March 19, 2012 -- Zhejiang Hisoar Pharmaceutical received approval from Japan to sell its API for meropenem, a beta-lactam antibiotic, in that country. The company’s Chuannan subsidiary was awarded a GMP compliance certificate by Japanese regulators. Hisoar said the approval will have a positive effect on the company’s performance, though it did not quantify the expected gain in revenue. More details....

Stock Symbol: (SHE: 002099)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES